CN104815628A - Molecular state living matter sampling agent used in living body blood - Google Patents
Molecular state living matter sampling agent used in living body blood Download PDFInfo
- Publication number
- CN104815628A CN104815628A CN201510156544.1A CN201510156544A CN104815628A CN 104815628 A CN104815628 A CN 104815628A CN 201510156544 A CN201510156544 A CN 201510156544A CN 104815628 A CN104815628 A CN 104815628A
- Authority
- CN
- China
- Prior art keywords
- resin
- new construction
- aperture
- living matter
- sampling agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3627—Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
- A61M1/3633—Blood component filters, e.g. leukocyte filters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/40—Aspects relating to the composition of sorbent or filter aid materials
- B01J2220/48—Sorbents characterised by the starting material used for their preparation
- B01J2220/4812—Sorbents characterised by the starting material used for their preparation the starting material being of organic character
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- External Artificial Organs (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention relates to a new molecular state living matter sampling agent styrene structure product used in living body blood, wherein the new molecular state living matter sampling agent styrene structure product is characterized in that the product is modified styrene-divinylbenzene macroporous adsorption resin.
Description
Technical field
The present invention relates to phenylethylene resin series, particularly comprise styrene-divinylbenzene, the modified product of styrenic anion exchanger resin and application thereof.
Background technology
Phenylethylene resin series in prior art, comprises styrene-divinylbenzene, and styrenic anion exchanger resin etc., as adsorbent and ion-exchanger, are widely used.
Use metallic compound such as FeCl
3as
phenylethylene resin seriesthe catalyst of post-crosslinking reaction has been routine techniques.But, all right in prior art up to now
phenylethylene resin seriescarry out functional modification or modification, all do not relate to and the constitute of the carbon chain backbone of resin or element are improved, after participating in post-crosslinking reaction, also do not enter the report in resin structure about catalyst.In the report of prior art, after post-crosslinking reaction, cleaning solvent is usually used thoroughly to be removed by post-crosslinking reaction catalyst.
In life science, lack a kind of simple and effective live body Dynamic sampling technological means, with Dynamic Extraction active molecular species sample from biological living blood.
Summary of the invention
the application is at first application for a patent for invention case " phenylethylene resin series new construction product, preparation method and its usage " application number: 201310347458.
the divisional application of X.
the object of the invention is to propose the new construction product of phenylethylene resin series, the technical scheme of preparation method and its usage.By changing phenylethylene resin series, comprise: styrene-divinyl benzene resin, and the structure of matter of polystyrene macroporous type anion exchange resin and gel-type anion exchanger resin, make it to have the New function being more suitable as blood-purifying adsorbing agent, can be used for intravital blood purification and Dynamic sampling from intravital blood.
the present invention includes three partial contents:
first: the new construction product of phenylethylene resin series, i.e. modified phenylethylene-divinylbenzene macroporous absorbent resin, and preparation method thereof.
this new construction product isthe carbochain of cancellated styrene-divinyl benzene resin skeleton embeds metallic element X, and its structural formula is C-X-C; Wherein C is carbon, and X element can be the metallic element with positive divalence or more.
The metallic element X embedded is ferric iron element or trivalent aluminium element, and its structural formula is C-Fe-C or C-Al-C; Wherein the 3rd price of iron Fe or aluminium Al is avtive spot Y; Strong and weak according to the ripple alive of element, Y site can be element F(fluorine successively) or Elements C l (chlorine) or element B r(bromine) or I(iodine); There is OH-(hydroxyl) time, also can be OH-; Or there is the functional group of contraposition valence state.
the present invention is the purposes of the new construction product of phenylethylene resin series:
the pore diameter range of the polystyrene new construction resin adopted can be 0-200nm, and pore volume and specific area are not limit; The Y site of the trivalent metallic element X embedded in its skeleton is by OH-occupy-place and/or by the occupy-place of monose loop chain and/or by the functional group occupy-place with contraposition valence state; Its purposes is used as the absorption sampling agent to molecule living matter in intravital blood; By Peripheral Circulation system or gi system, live body Dynamic sampling is carried out to living matter wherein.
resin aperture is prepared when resin polymerization reacts, relevant with the pore-foaming agent material adopted.The inventive method, when participating in insertion reaction with metallic catalyst, has dilating effect to resin aperture.Such as aforementioned, there is not hole in gel shape resin anion (R.A.), but creates hole originally in course of reaction, also defines by process the space that specific area reaches 1900 square meters/every grammes per square metre.
according to clinical needs, the new construction product of medical phenylethylene resin series according to its pore diameter range, following differentiation can be done:
16 of embodiment:
the aperture 0-100nm of the polystyrene new construction resin adopted, the resin wherein containing 80-100nm particle diameter is not less than 60%.
17 of embodiment:
the aperture 0-140nm of the polystyrene new construction resin adopted, the resin wherein containing 100-140nm particle diameter is not less than 60%.
18 of embodiment:
the aperture 0-200nm of the polystyrene new construction resin adopted, the resin wherein containing 140-200nm particle diameter is not less than 60%.
when being used as intravital blood Middle molecule state living matter sampling agent use,the different valence state material function group had with Y site and the resin of different pore size are loaded in sampler respectively.The similar blood perfusion device of structure of this sampler, using method also roughly the same.After completing sampling, sampler is extractd from blood extracorporeal circulation system, will the living beings wash-out in sampler resin be adsorbed on by the method for cleaning.Because resin of the present invention is the living matter adopting physical absorption principle separation and Extraction blood Middle molecule state, be adsorbed in resin voids of the present invention and resin surface living matter can in nutrient environment for a long time in keep its vital activity, for life science provides a kind of important technological means.
In such use embodiment of the present invention, the pore diameter range of resin is from " 0 ", and refer to that aperture is " 0 ", namely resin particle does not have hole.But in a sampler, the gap between resin particle also can be regarded as in " aperture ", then " aperture " even should cannot measure concrete data, it perhaps can be very large, the aperture that serious offense resin particle can have.
Also any restriction is not done to " pore volume " and " specific area " in such use embodiment.Because for macroporous absorbent resin, the most important condition that restriction adsorbed material enters resin voids is aperture.After aperture is determined, pore volume and specific area are proportional with Adsorbent rate respectively.And adsorption rate and aperture, proportionate relationship between pore volume and specific area are more statistics contents, not there is disruptive technology invention meaning of the present invention.
In a word, the present invention
the new construction product of phenylethylene resin series is used in blood perfusion device He in sampler makes adsorbent, due to the existence of avtive spot Y point, and can with multiple virulence factor in its polarity adsorption function absorption blood; And can be occupied by monose loop chain due to Y point, all kinds of surface have glycan molecule, glycoprotein molecule living matter can because of compatibility docile wound on it; This polarity absorption and compatibility are wound around.
the effect of the avtive spot Y point that resin material of the present invention has, also be that Y point can by corresponding modification, occupied by the molecular function group with required function, thus for the sampling polymeric adsorbent of all kinds of living matter molecule is adsorbed in preparation targetedly, provide technology platform.
resin of the present invention is used for the agent of living matter living body sampling, and its using method is identical with the using method as blood-purifying adsorbing agent in blood perfusion device, for life science provides a kind of simple and effective sampling technique means.
Naval stores new construction technical scheme of the present invention
all never see the report of any open source literature before this,be unprecedented technical innovation in this area, compared with prior art there is outstanding substantive distinguishing features.
the new construction product of phenylethylene resin series of the present invention uses as sampling adsorbent, in blood, the sampling of living body molecule state living matter is verified in test.The present invention has significant progress than existing sampling technique.
Claims (7)
1. for the polystyrene new construction product of intravital blood Middle molecule state living matter sampling agent, it is characterized in that: be modified phenylethylene-divinylbenzene macroporous absorbent resin, the carbochain of cancellated styrene-divinyl benzene resin skeleton embeds metallic element X, and its structural formula is C-X-C; Wherein C is carbon; The metallic element X that the carbochain of cancellated styrene-divinyl benzene resin skeleton embeds be ferric iron element or trivalent aluminium element time, its structural formula is C-Fe-C or C-Al-C; Wherein the 3rd price of iron Fe or aluminium Al is avtive spot Y; Strong and weak according to the activity of element, Y site can be element F(fluorine successively) or Elements C l (chlorine) or element B r(bromine) or I(iodine); There is OH-(hydroxyl) time, also can be OH-; Or there is the functional group of contraposition valence state.
2., as claimed in claim 1 for the polystyrene new construction product of intravital blood Middle molecule state living matter sampling agent, it is characterized in that: the aperture 0-200nm of the polystyrene new construction resin of employing, pore volume and specific area are not limit; The Y point of the trivalent metallic element iron embedded in its carbochain or aluminium is by OH-occupy-place and/or by the occupy-place of monose loop chain and/or by the functional group occupy-place with contraposition valence state.
3., as claimed in claim 2 for the polystyrene new construction product of intravital blood Middle molecule state living matter sampling agent, it is characterized in that: the aperture 0-200nm adopting new construction resin, the resin wherein containing 100-200nm particle diameter is not less than 60%.
4., as claimed in claim 2 for the polystyrene new construction product of intravital blood Middle molecule state living matter sampling agent, it is characterized in that: the aperture 0-140nm adopting new construction resin, the resin wherein containing 100-140nm particle diameter is not less than 60%.
5., as claimed in claim 2 for the polystyrene new construction product of intravital blood Middle molecule state living matter sampling agent, it is characterized in that: the aperture 0-100nm adopting new construction resin, the resin wherein containing 80-100nm particle diameter is not less than 60%.
6. the polystyrene new construction product for intravital blood Middle molecule state living matter sampling agent as described in claim 2,3,4,5, it is characterized in that: when making adsorbent for blood perfusion device and using, can select according to the valence state attribute of AIDS virus molecule of absorption and particle diameter and there is contraposition valence state functional group, and the resin being suitable for aperture is to fill blood perfusion device; The mode of filling can be that a kind of resin of pore diameter range loads a tank, and blood perfusion device is according to the material valence state attributive classification in in-built resin aperture and Y site; Or according to the direction arrangement flowed through along blood, the large resin filling in aperture is at upstream position; Be loaded in perfusion device according to the order layering that aperture is descending is mixed, the material valence state delamination classification had according to the element or functional group that occupy Y point.
7. as described in claim 2,3,4,5 for intravital blood Middle molecule state living matter sampling agent new construction product, it is characterized in that: use for doing sampling agent, the resin of the different valence state attribute that different pore size and Y point have, difference or in proportion mixed filling are in sampler.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510156544.1A CN104815628B (en) | 2013-08-12 | 2013-08-12 | A kind of purposes of modified phenylethylene-divinylbenzene macroporous absorbent resin |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310347458.XA CN103483487B (en) | 2013-08-01 | 2013-08-12 | Novel structure product, preparation method and use of styrenic resin |
| CN201510156544.1A CN104815628B (en) | 2013-08-12 | 2013-08-12 | A kind of purposes of modified phenylethylene-divinylbenzene macroporous absorbent resin |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310347458.XA Division CN103483487B (en) | 2013-08-01 | 2013-08-12 | Novel structure product, preparation method and use of styrenic resin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104815628A true CN104815628A (en) | 2015-08-05 |
| CN104815628B CN104815628B (en) | 2017-08-11 |
Family
ID=53744341
Family Applications (10)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510291617.8A Pending CN104857015A (en) | 2013-08-12 | 2013-08-12 | Styrene type novel-structure adsorption resin for de-addiction and detoxification |
| CN201510156544.1A Active CN104815628B (en) | 2013-08-12 | 2013-08-12 | A kind of purposes of modified phenylethylene-divinylbenzene macroporous absorbent resin |
| CN201510120428.4A Active CN104689803B (en) | 2013-08-12 | 2013-08-12 | For adsorbing the phenylethylene resin series of hepatitis viruse in blood |
| CN201510291604.0A Active CN104923185B (en) | 2013-08-12 | 2013-08-12 | Medical polymeric adsorbent for removing H N macromoleculars virus |
| CN201510291587.0A Pending CN104887699A (en) | 2013-08-12 | 2013-08-12 | Medical adsorptive resin for clearing away factors blocking nerve conduction |
| CN201510291616.3A Pending CN104887700A (en) | 2013-08-12 | 2013-08-12 | Medical adsorptive resin for eliminating syphilis and sexual disease pathogenic factors |
| CN201510291602.1A Active CN104941607B (en) | 2013-08-12 | 2013-08-12 | Styrene resin adsorption agent for clearing high beta2 microglobulin in blood |
| CN201510120605.9A Active CN104689804B (en) | 2013-08-12 | 2013-08-12 | For adsorbing the phenylethylene resin series of AIDS virus molecule in blood |
| CN201510291618.2A Pending CN104922147A (en) | 2013-08-12 | 2013-08-12 | New structure medical resin for eliminating high cholesterol |
| CN201510120761.5A Active CN104667897B (en) | 2013-08-12 | 2013-08-12 | For adsorbing high endotoxic phenylethylene resin series in blood |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510291617.8A Pending CN104857015A (en) | 2013-08-12 | 2013-08-12 | Styrene type novel-structure adsorption resin for de-addiction and detoxification |
Family Applications After (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510120428.4A Active CN104689803B (en) | 2013-08-12 | 2013-08-12 | For adsorbing the phenylethylene resin series of hepatitis viruse in blood |
| CN201510291604.0A Active CN104923185B (en) | 2013-08-12 | 2013-08-12 | Medical polymeric adsorbent for removing H N macromoleculars virus |
| CN201510291587.0A Pending CN104887699A (en) | 2013-08-12 | 2013-08-12 | Medical adsorptive resin for clearing away factors blocking nerve conduction |
| CN201510291616.3A Pending CN104887700A (en) | 2013-08-12 | 2013-08-12 | Medical adsorptive resin for eliminating syphilis and sexual disease pathogenic factors |
| CN201510291602.1A Active CN104941607B (en) | 2013-08-12 | 2013-08-12 | Styrene resin adsorption agent for clearing high beta2 microglobulin in blood |
| CN201510120605.9A Active CN104689804B (en) | 2013-08-12 | 2013-08-12 | For adsorbing the phenylethylene resin series of AIDS virus molecule in blood |
| CN201510291618.2A Pending CN104922147A (en) | 2013-08-12 | 2013-08-12 | New structure medical resin for eliminating high cholesterol |
| CN201510120761.5A Active CN104667897B (en) | 2013-08-12 | 2013-08-12 | For adsorbing high endotoxic phenylethylene resin series in blood |
Country Status (1)
| Country | Link |
|---|---|
| CN (10) | CN104857015A (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104857015A (en) * | 2013-08-12 | 2015-08-26 | 天津市阳权医疗器械有限公司 | Styrene type novel-structure adsorption resin for de-addiction and detoxification |
| US20180185492A1 (en) * | 2015-07-09 | 2018-07-05 | Jie Yu | Micro-nano medical adsorbent resin powder material |
| CN107789691A (en) * | 2016-09-07 | 2018-03-13 | 天津市阳权医疗器械有限公司 | It is exclusively used in treating the disposable blood perfusion device of endotoxemia |
| CN108031454B (en) * | 2017-12-19 | 2021-08-13 | 陈荣胜 | Blood purification adsorbent with physical specificity selectivity and preparation method thereof |
| CN113262762B (en) * | 2021-05-06 | 2023-04-21 | 西安蓝深新材料科技股份有限公司 | Adsorption material for blood perfusion and preparation method thereof |
| CN114085829B (en) * | 2021-11-18 | 2023-08-11 | 军事科学院军事医学研究院环境医学与作业医学研究所 | Efficient enrichment method for viruses in environmental medium |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1378879A (en) * | 2001-04-06 | 2002-11-13 | 中国科学院化学研究所 | Solid photocatalyst and its preparing process |
| EP1801072A1 (en) * | 2005-12-20 | 2007-06-27 | Blücher GmbH | Actived carbon with catalytic activity |
| CN102268114A (en) * | 2011-05-24 | 2011-12-07 | 南京大学 | Defluorinating resin with compound functions and preparation method thereof |
| CN102847521A (en) * | 2011-06-28 | 2013-01-02 | 于杰 | Macro-porous adsorption resin and its application |
| CN103483487B (en) * | 2013-08-01 | 2015-06-24 | 天津市阳权医疗器械有限公司 | Novel structure product, preparation method and use of styrenic resin |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4383088A (en) * | 1982-02-04 | 1983-05-10 | Combustion Engineering, Inc. | Organic polymer layered dichalcogenides |
| CN100478370C (en) * | 2006-05-12 | 2009-04-15 | 南京大学 | Method for controlloing oxygen containing functional group in surface in synthesizeing adsorptive resin of crosslinked polystyrene |
| CN102335465A (en) * | 2010-07-27 | 2012-02-01 | 天津市阳权医疗器械有限公司 | Blood perfusion device for treating uremia |
| CN102335466A (en) * | 2010-07-27 | 2012-02-01 | 天津市阳权医疗器械有限公司 | Blood perfusion device for treating hypertension |
| CN101912770B (en) * | 2010-09-03 | 2012-07-04 | 中国科学院长春应用化学研究所 | Polymeric adsorbent and preparation method thereof |
| CN104857015A (en) * | 2013-08-12 | 2015-08-26 | 天津市阳权医疗器械有限公司 | Styrene type novel-structure adsorption resin for de-addiction and detoxification |
-
2013
- 2013-08-12 CN CN201510291617.8A patent/CN104857015A/en active Pending
- 2013-08-12 CN CN201510156544.1A patent/CN104815628B/en active Active
- 2013-08-12 CN CN201510120428.4A patent/CN104689803B/en active Active
- 2013-08-12 CN CN201510291604.0A patent/CN104923185B/en active Active
- 2013-08-12 CN CN201510291587.0A patent/CN104887699A/en active Pending
- 2013-08-12 CN CN201510291616.3A patent/CN104887700A/en active Pending
- 2013-08-12 CN CN201510291602.1A patent/CN104941607B/en active Active
- 2013-08-12 CN CN201510120605.9A patent/CN104689804B/en active Active
- 2013-08-12 CN CN201510291618.2A patent/CN104922147A/en active Pending
- 2013-08-12 CN CN201510120761.5A patent/CN104667897B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1378879A (en) * | 2001-04-06 | 2002-11-13 | 中国科学院化学研究所 | Solid photocatalyst and its preparing process |
| EP1801072A1 (en) * | 2005-12-20 | 2007-06-27 | Blücher GmbH | Actived carbon with catalytic activity |
| CN102268114A (en) * | 2011-05-24 | 2011-12-07 | 南京大学 | Defluorinating resin with compound functions and preparation method thereof |
| CN102847521A (en) * | 2011-06-28 | 2013-01-02 | 于杰 | Macro-porous adsorption resin and its application |
| CN103483487B (en) * | 2013-08-01 | 2015-06-24 | 天津市阳权医疗器械有限公司 | Novel structure product, preparation method and use of styrenic resin |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104689804A (en) | 2015-06-10 |
| CN104887700A (en) | 2015-09-09 |
| CN104922147A (en) | 2015-09-23 |
| CN104887699A (en) | 2015-09-09 |
| CN104667897A (en) | 2015-06-03 |
| CN104941607A (en) | 2015-09-30 |
| CN104689803A (en) | 2015-06-10 |
| CN104689804B (en) | 2016-03-02 |
| CN104815628B (en) | 2017-08-11 |
| CN104667897B (en) | 2016-03-02 |
| CN104923185B (en) | 2017-10-24 |
| CN104857015A (en) | 2015-08-26 |
| CN104689803B (en) | 2016-03-02 |
| CN104941607B (en) | 2017-02-01 |
| CN104923185A (en) | 2015-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104815628A (en) | Molecular state living matter sampling agent used in living body blood | |
| Zhao et al. | Controllable synthesis of porous Cu-BTC@ polymer composite beads for iodine capture | |
| Bullen et al. | A revised pseudo-second-order kinetic model for adsorption, sensitive to changes in adsorbate and adsorbent concentrations | |
| Zhang et al. | Structural evolution of lanthanum hydroxides during long-term phosphate mitigation: Effect of nanoconfinement | |
| Maya et al. | Automatic in-syringe dispersive microsolid phase extraction using magnetic metal–organic frameworks | |
| Inczédy | Analytical applications of ion exchangers | |
| Chen et al. | Composite hydrogel particles encapsulated ammonium molybdophosphate for efficiently cesium selective removal and enrichment from wastewater | |
| Sun et al. | Adsorption removal of tannic acid from aqueous solution by polyaniline: Analysis of operating parameters and mechanism | |
| Umeno et al. | Preparation and adsorptive properties of membrane-type adsorbents for lithium recovery from seawater | |
| Luqman | Ion exchange technology I: theory and materials | |
| Maya et al. | Emerging materials for sample preparation | |
| Solbrå et al. | Cesium and Strontium Ion Exchange on the Framework Titanium Silicate M2Ti2O3SiO4⊙ n H2O (M= H, Na) | |
| Puttamraju et al. | Evidence of tunable on− off sorption behaviors of metal oxide nanoparticles: Role of ion exchanger support | |
| Quigley et al. | Sorption irreversibility and coagulation behavior of 234Th with marine organic matter | |
| Naeimi et al. | Modification and magnetization of MOF (HKUST-1) for the removal of Sr2+ from aqueous solutions. Equilibrium, kinetic and thermodynamic modeling studies | |
| Zhang et al. | Enhanced removal of iodide ions by nano Cu2O/Cu modified activated carbon from simulated wastewater with improved countercurrent two-stage adsorption | |
| Nur et al. | Removing rubidium using potassium cobalt hexacyanoferrate in the membrane adsorption hybrid system | |
| Liu et al. | Kinetics and thermodynamics of efficient phosphorus removal by a composite fiber | |
| Ma et al. | Highly Efficient Uptake of Cs+ by Robust Layered Metal–Organic Frameworks with a Distinctive Ion Exchange Mechanism | |
| CN107569730A (en) | A kind of device applied to haemodialysis | |
| Jeyaseelan et al. | Construction of magnetic particles sprayed hydroxyapatite based bio-ceramic beads for selective fluoride removal | |
| CN108047361A (en) | A kind of Properties of Magnetic Chelating Resins, its preparation method and its application in combined pollution water body purification | |
| Zhi et al. | The study of amidoxime-functionalized cellulose separate Th (IV) from aqueous solution | |
| Pournara et al. | Zirconium (IV) metal organic frameworks with highly selective sorption for diclofenac under batch and continuous flow conditions | |
| Thakur et al. | Selective quantification of diclofenac from groundwater and pharmaceutical samples by magnetic molecularly imprinted polymer-based sorbent coupled with the HPLC-PDA detection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190807 Address after: 264210 No. 1 Weigao Road, Chucun Town, Weihai Torch High-tech Industrial Development Zone, Shandong Province Patentee after: Weihai Weigaoyangquan Biological Co., Ltd. Address before: 300222 north side of outer ring road, East Mountain Road, Jinnan District, Tianjin Patentee before: Tianjin Yangquan Medical Devices Co., Ltd. |